Live Breaking News & Updates on Catalyst Pharmaceuticals Stock Performance

Stay updated with breaking news from Catalyst pharmaceuticals stock performance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Insider Sells $121,183.87 in Stock

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) insider Carmen Jeffrey Del sold 7,541 shares of the company’s stock in a transaction on Friday, June 7th. The stock was sold at an average price of $16.07, for a total transaction of $121,183.87. Following the completion of the sale, the insider now owns 18,427 shares of […] ....

Boston , Massachusetts , United-states , Kennedy-capital-management , Catalyst-pharmaceuticals-stock-performance , Vanguard-group-inc , Cantor-fitzgerald , Nasdaq , Institutional-investors-weigh-in-on-catalyst-pharmaceuticals , Quarter-for-catalyst-pharmaceuticals , Janus-henderson-group

Catalyst Pharmaceuticals (NASDAQ:CPRX) Upgraded to Buy by StockNews.com

Catalyst Pharmaceuticals (NASDAQ:CPRX – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued on Friday. Several other analysts also recently commented on CPRX. Oppenheimer reaffirmed an “outperform” rating and set a $29.00 target price on shares of Catalyst Pharmaceuticals in a […] ....

United-states , America , Gary-ingenito , Brian-elsbernd , Dekabank-deutsche-girozentrale , Catalyst-pharmaceuticals , Analyst-recommendations-for-catalyst-pharmaceuticals , Catalyst-pharmaceuticals-company-profile , Citigroup , Catalyst-pharmaceuticals-inc , Securities-exchange-commission , Cantor-fitzgerald

Summit Global Investments Lowers Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)

Summit Global Investments Lowers Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , America , Brian-elsbernd , Sherbrooke-park-advisers , Financial-services-group-inc , Cantor-fitzgerald , News-ratings-for-catalyst-pharmaceuticals-daily , Catalyst-pharmaceuticals-stock-performance , Nisa-investment-advisors , Parkside-financial-bank , Insider-activity-at-catalyst-pharmaceuticals , Securities-exchange-commission

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Receives $26.43 Average Price Target from Analysts

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Receives $26.43 Average Price Target from Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , America , Davids-tierney , Catalyst-pharmaceuticals-inc , News-ratings-for-catalyst-pharmaceuticals-daily , Parkside-financial-bank , Sherbrooke-park-advisers , Catalyst-pharmaceuticals-company-profile , Catalyst-pharmaceuticals , Tower-research-capital , Catalyst-pharmaceuticals-stock-performance

Catalyst Pharmaceuticals, Inc. Expected to Post Q4 2025 Earnings of $0.65 Per Share (NASDAQ:CPRX)

Catalyst Pharmaceuticals, Inc. Expected to Post Q4 2025 Earnings of $0.65 Per Share (NASDAQ:CPRX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Switzerland , Illinois , United-states , American , Swiss , Davids-tierney , Catalyst-pharmaceuticals-inc , Cantor-fitzgerald , American-century-companies-inc , Nasdaq , Catalyst-pharmaceuticals